Company Filing History:
3 out of 88 
2 out of 961 
Years Active: 2020-2025
Title: The Innovative Contributions of Roberto Tinoco
Introduction
Roberto Tinoco is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of 3 patents, Tinoco's work focuses on the relationship between gut microbiota and cancer.
Latest Patents
Tinoco's latest patents include groundbreaking methods for treating cancer by regulating gut microbiota. One of his notable inventions involves the ubiquitin ligase, RNF5, which plays a crucial role in gut microbiota composition and influences the immune checkpoint response to tumors. His research indicates that RNF5 deficient animals show significant inhibition of tumor development, alongside an altered gut microbiota composition. The patents disclose methods of treating cancer by administering selected bacterial species and/or prebiotics that promote the growth of these bacterial species. Additionally, he explores the combination of these treatments with anti-cancer agents to enhance therapeutic efficacy.
Career Highlights
Throughout his career, Tinoco has worked with esteemed organizations such as the Technion Research & Development Foundation Limited and the Sanford Burnham Prebys Medical Discovery Institute. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Tinoco has collaborated with notable colleagues, including Yan Li and Scott Peterson. These partnerships have further enriched his research endeavors and have led to significant advancements in understanding cancer treatment.
Conclusion
Roberto Tinoco's innovative work in the field of cancer treatment through gut microbiota regulation showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic strategies for cancer patients.